Vanda Pharmaceuticals is committed to making HETLIOZ® (tasimelteon) accessible to people living with Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances in SMS. HETLIOZSolutions™ was created to support people who have been diagnosed with Non-24 and nighttime sleep disturbances in SMS.
The program can assist with coordinating care to help answer insurance questions, as well as provide financial support and educational resources. And most importantly, by letting you know that you are not alone on this journey.
If you have questions about your insurance coverage, your prescription delivery or options for financial assistance, help is available through HETLIOZSolutions™ by calling 1-844-HETLIOZ. That's 1-844-438-5469, from 9:00AM to 8:00PM, Eastern Standard Time.
HETLIOZSolutions™ helps by:
*HETLIOZ® is only available through specialty pharmacies that distribute the medication directly to your door. Specialty prescriptions typically require special handling, administration or monitoring.
Call HETLIOZSolutions™ at 1-844-HETLIOZ. That's 1-844-438-5469. You or your doctor can make the first call. You'll be assigned a Patient Care Coordinator, who will explain how to enroll in the HETLIOZSolutions™ program and offer assistance with obtaining a prescription for HETLIOZ® (tasimelteon).
Once you have been diagnosed, you and your physician will need to fill out and sign the HETLIOZSolutions™ Prescription and Service Request Form. Then fax it to 1-844-364-2424. Please note that your insurance company may require additional documentation to authorize coverage for HETLIOZ®. Download your copy of the HETLIOZSolutions™ Prescription and Service Request Form, or listen to the audio version.
For every patient, HETLIOZSolutions™ will determine what type of insurance coverage is available for HETLIOZ®. Financial assistance programs are available to help cover costs of treatment. If you don't currently have any insurance coverage or you are underinsured, your Patient Care Coordinator will help you by seeking alternative coverage or financial support.
Together, you'll discuss your insurance coverage. A Patient Care Coordinator from HETLIOZSolutions™ will work with you one-on-one.
Your Patient Care Coordinator will help you understand your insurance benefits by:
After reviewing your insurance benefits and discussing them with your doctor, your Patient Care Coordinator will forward your information to a specialty pharmacy. The specialty pharmacy partner will work with you to coordinate any final details regarding starting you on therapy with HETLIOZ® (tasimelteon).
Your Patient Care Coordinator will continue to follow your progress by:
You will also receive ongoing follow-up calls from your Patient Care Coordinator.
HETLIOZ® (HeT-lee-ōz) [tasimelteon] capsules are indicated for the treatment of:
HETLIOZ LQ™ (HeT-lee-oz el-Cue) oral suspension is indicated for:
Important Safety Information
HETLIOZ® may cause drowsiness. After taking HETLIOZ®, limit your activity to preparing for bed. HETLIOZ® can potentially impair your ability to perform activities that require complete mental alertness.
The most common side effects associated with HETLIOZ® include headache, elevated liver enzymes (ALT), nightmares or abnormal dreams, and upper respiratory or urinary tract infection. These side effects may occur more frequently in patients 65 years of age or older. Adverse reactions were similar in patients treated for (Non-24) and patients with SMS treated for nighttime sleep disturbances. Adverse reactions were also similar in pediatric patients (3 years to 15 years) who received HETLIOZ LQ™ oral suspension, and patients ≥16 years of age who received HETLIOZ® capsules.
Tell your healthcare provider about all of the medicines you're taking. HETLIOZ® should not be taken in combination with fluvoxamine or rifampin.
Tell your healthcare provider about all of your health conditions, including whether you are pregnant, are planning to become pregnant, or are breastfeeding. HETLIOZ® has not been studied in pregnant women.
The safety and effectiveness of HETLIOZ® for the treatment of Non-24-Hour in children have not been established. The safety and effectiveness of HETLIOZ LQ™ oral suspension for the treatment of nighttime sleep disturbances in SMS have been established in pediatric patients 3 years and older.
HETLIOZ® is not recommended for use in patients with severe liver problems.
Consumer Important Safety Information
You are encouraged to report side effects of prescription drugs to the FDA. To report side effects, contact Vanda Pharmaceuticals Inc. at 1-844-438-5469 or www.hetlioz.com or FDA at 1-800-FDA-0178 or www.fda.gov/medwatch.
For more information, ask your healthcare provider or call 1-844-HETLIOZ (1-844-438-5469).
This information does not take the place of talking with your healthcare provider for medical advice about your condition or treatment.
Download an accessible PDF or listen to the full US Prescribing Information. You can also hear the full US Prescribing Information by calling 1-844-HETLIOZ (1-844-438-5469).